Zobrazeno 1 - 10
of 3 330
pro vyhledávání: '"Glasebrook, A."'
Autor:
Kuhn, Susan
Publikováno v:
Fortune. 10/3/1994, Vol. 130 Issue 7, p46-46. 1p. 1 Color Photograph, 1 Chart, 1 Graph.
Autor:
Goldberg, Steven T.
Publikováno v:
Kiplinger's Personal Finance Magazine. Jan96, Vol. 50 Issue 1, p113. 1/3p. 1 Color Photograph.
Autor:
Rao, Y. K. Raghunatha
Publikováno v:
Current Science, 1951 Jun 01. 20(6), 168-169.
Externí odkaz:
https://www.jstor.org/stable/24214326
Autor:
Highet, H. C.
Publikováno v:
Science Progress (1933- ), 1951 Oct 01. 39(156), 740-741.
Externí odkaz:
https://www.jstor.org/stable/43422965
Autor:
Jason Manro, Carmine Carpenito, Flora Huang, Mathilde Poussin, Arlene Sereno, Xiufeng Wu, Shanshan Cao, Andrew Glasebrook, Daniel J Powell Jr, Stephen J Demarest
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Bispecific T cell engagers represent the majority of bispecific antibodies (BsAbs) entering the clinic to treat metastatic cancer. The ability to apply these agents safely and efficaciously in the clinic, particularly for solid tumors, has
Externí odkaz:
https://doaj.org/article/8e718885296b40cb8b147fa475c01d77
Autor:
Joel Crespo, Yi Ting Koh, Ningjie Hu, Paul A Moore, Ezio Bonvini, Andrew L Glasebrook, Andrea P Martin, Robert J Benschop
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0245917 (2021)
Pre-clinical murine models are critical for translating drug candidates from the bench to the bedside. There is interest in better understanding how anti-human CD3 therapy works based on recent longitudinal studies of short-term administration. Altho
Externí odkaz:
https://doaj.org/article/284cea3843ea48808b3b32fa3cdf258b
Autor:
Grese, Timothy A., Sluka, James P., Bryant, Henry U., Cullinan, George J., Glasebrook, Andrew L., Jones, Charles D., Matsumoto, Ken, Palkowitz, Alan D., Sato, Masahiko, Termine, John D., Winter, Mark A., Yang, Na N., Dodge, Jeffrey A.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1997 Dec 01. 94(25), 14105-14110.
Externí odkaz:
https://www.jstor.org/stable/43867
Publikováno v:
Science, 1996 Aug . 273(5279), 1222-1225.
Externí odkaz:
https://www.jstor.org/stable/2891249
Autor:
Crespo, Joel, Koh, Yi Ting, Hu, Ningjie, Moore, Paul A., Bonvini, Ezio, Glasebrook, Andrew L., Martin, Andrea P., Benschop, Robert J.
Publikováno v:
PLoS ONE; 2/17/2021, Vol. 16 Issue 2, p1-17, 17p
Autor:
S.J. Demarest, Mathilde Poussin, Carmine Carpenito, Jason Manro, Xiufeng Wu, Shanshan Cao, F. Huang, Arlene Sereno, Andrew L. Glasebrook, Daniel J. Powell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundBispecific T cell engagers represent the majority of bispecific antibodies (BsAbs) entering the clinic to treat metastatic cancer. The ability to apply these agents safely and efficaciously in the clinic, particularly for solid tumors, has